Pharma execs pitch ideas at JPM20 to lower drug costs. None of them include dropping their own prices.

16 January 2020 - CEOs from the world’s largest pharmaceutical companies pitched ideas for lowering drug prices at the J.P. Morgan ...

Read more →

Novartis strikes deal with UK to provide cholesterol drug to high-risk patients

13 January 2020 - Pharmaceutical giant Novartis reached a deal with the U.K. to provide its late-stage cholesterol drug, inclisiran, to ...

Read more →

Neurelis announces FDA approval for seizure rescue treatment Valtoco (diazepam nasal spray) that incorporates the science of Intravail for consistent and reliable absoption

13 January 2020 - Valtoco is the first nasal spray approved by the FDA as a rescue treatment for people with ...

Read more →

High cost of multiple sclerosis medicines is forcing many patients to take ‘drastic actions’

13 January 2020 - The high cost of multiple sclerosis treatments has forced 40% of patients to take “drastic actions” ...

Read more →

Drug makers test new ways to pay for six figure treatments

13 January 2020 - Public pressure, insurer pushback and better data are driving drug companies to tinker with how they get ...

Read more →

Lynparza regulatory submission granted priority review in the US for first-line maintenance treatment with bevacizumab in advanced ovarian cancer

13 January 2020 - Submission based on Phase III PAOLA-1 trial for patients with advanced ovarian cancer regardless of biomarker ...

Read more →

SMC - January 2020 decisions

13 January 2020 - Medicines which can be used to treat prostate cancer, primary progressive multiple sclerosis, a rare form ...

Read more →

Myeloma NZ calls on PHARMAC to make good on access deal

14 January 2020 - Myeloma New Zealand is today calling on PHARMAC to make good on their proposal to widen ...

Read more →

In home care plan to cut hospital costs

13 January 2020 - Patients with mental health problems, chronic disease and undergoing rehabilitation will be increasingly diverted out of ...

Read more →

Ensuring continued access to affordable PBS medicines for those impacted by bushfires

10 January 2020 - A joint release with the Hon. Stuart Robert MP, Minister for the National Disability Insurance Scheme and ...

Read more →

Aquestive Therapeutics receives FDA response to Citizen’s Petition

12 January 2020 - Aquestive Therapeutics today reported that the U.S. FDA issued a response letter dated 10 January 2020 denying ...

Read more →

Atomoxetine – further delay in change of funded brand and open access

10 January 2020 - PHARMAC is advising all interested parties that there is a further delay in the listing of ...

Read more →

Sanofi secures expanded European approval for Toujeo in type 1 diabetes

10 January 2020 - Sanofi has revealed that the European Commission has expanded the existing label for Toujeo (insulin glargine ...

Read more →

The Tories must learn from the Orkambi victory and keep drug-pricing off the table

12 January 2020 - To match its rhetoric on the NHS, the government has to legally commit to preventing drug-pricing being ...

Read more →

The FDA is in trouble. Here’s how to fix it.

11 January 2020 - Some New Year’s resolutions for the incoming boss. ...

Read more →

At 16, she’s a pioneer in the fight to cure sickle cell disease

11 January 2020 - Helen Obando is the youngest person ever to get a gene therapy that scientists hope will cure ...

Read more →